<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01156337</url>
  </required_header>
  <id_info>
    <org_study_id>G.F. Ingrassia Hospital,Italy</org_study_id>
    <nct_id>NCT01156337</nct_id>
  </id_info>
  <brief_title>Sodium Management in Acute and Chronic Heart Failure</brief_title>
  <acronym>SMAC-HF</acronym>
  <official_title>Sodium Management in Acute and Chronic Phases in Patients With New York Heart Association Class III (Class C) Heart Failure. Short and Long Term Findings.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale G. F. Ingrassia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Naples</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Buccheri La Ferla Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ospedale G. F. Ingrassia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was aimed to verify the effects of Hypertonic saline solution (HSS) and a moderate
      sodium (Na) restriction plus high furosemide dose in the short term (hospitalization time)
      and a moderate Na restriction in the long term on readmissions and mortality in patients in
      III NYHA class.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2000</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>readmission for HF worsening</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>low sodium diet 80 mmol/day</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate sodium intake 120 mmol/day</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in III NYHA class HF
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Decompensated HF due to ischemic or nonischemic cardiomyopathy,

          -  &gt;18 years of age,

          -  HF according to Framingham criteria

          -  NYHA functional class III

          -  EF &lt;40%,

          -  Serum creatinine &lt;2,5 mg/dL

          -  BUN &lt;60 mg/dL,

        Exclusion criteria:

          -  NYHA class &gt; III or &lt; III,

          -  Cerebral vascular disease,

          -  Dementia,

          -  Cancer,

          -  Uncompensated diabetes,

          -  Severe hepatic disease

          -  Patients requiring pacemaker

          -  Previous RCT implantation

          -  Alcoholic habit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>GF Ingrassia Hospital</name>
      <address>
        <city>Palermo</city>
        <zip>90100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2010</study_first_submitted>
  <study_first_submitted_qc>July 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2010</study_first_posted>
  <last_update_submitted>November 18, 2011</last_update_submitted>
  <last_update_submitted_qc>November 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2011</last_update_posted>
  <keyword>Heart failure III NYHA class</keyword>
  <keyword>Furosemide</keyword>
  <keyword>Sodium</keyword>
  <keyword>water restriction</keyword>
  <keyword>decompensated heart failure</keyword>
  <keyword>Hypertonic saline solution</keyword>
  <keyword>Moderate sodium restriction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

